Jane Street Group, LLC Beam Therapeutics Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 188,091 shares of BEAM stock, worth $4.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188,091
Previous 450,216 58.22%
Holding current value
$4.96 Million
Previous $10.5 Million 56.31%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $5.92 Million - $8.69 Million
-262,125 Reduced 58.22%
188,091 $4.61 Million
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $5.91 Million - $9.09 Million
278,399 Added 162.03%
450,216 $10.5 Million
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $4.13 Million - $7.94 Million
-176,231 Reduced 50.63%
171,817 $5.68 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $5.87 Million - $10.2 Million
331,890 Added 2054.03%
348,048 $9.47 Million
Q3 2023

Nov 14, 2023
SELL
$23.01 - $32.46 $2.7 Million - $3.8 Million
-117,197 Reduced 87.88%
16,158 $388,000
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $2.7 Million - $3.32 Million
92,210 Added 224.11%
133,355 $4.26 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $210,959 - $341,383
-6,997 Reduced 14.53%
41,145 $1.26 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $1.77 Million - $2.48 Million
48,142 New
48,142 $1.88 Million
Q2 2022

Aug 16, 2022
SELL
$29.86 - $62.36 $678,717 - $1.42 Million
-22,730 Reduced 22.55%
78,081 $3.02 Million
Q1 2022

May 17, 2022
BUY
$53.73 - $82.16 $4.3 Million - $6.57 Million
79,982 Added 383.99%
100,811 $5.78 Million
Q4 2021

Feb 15, 2022
SELL
$68.02 - $99.06 $130,462 - $189,997
-1,918 Reduced 8.43%
20,829 $1.66 Million
Q3 2021

Nov 16, 2021
SELL
$84.37 - $133.6 $2.86 Million - $4.54 Million
-33,955 Reduced 59.88%
22,747 $1.98 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $1.87 Million - $3.76 Million
29,192 Added 106.11%
56,702 $7.3 Million
Q1 2021

May 18, 2021
BUY
$71.28 - $120.75 $248,482 - $420,934
3,486 Added 14.51%
27,510 $2.2 Million
Q4 2020

Feb 17, 2021
BUY
$22.24 - $95.63 $534,293 - $2.3 Million
24,024 New
24,024 $1.96 Million

Others Institutions Holding BEAM

# of Institutions
235
Shares Held
75.1M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.86B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email